This site is intended for US Residents only.

Talking to your

doctor about your

treatment options

SHOULD I TRANSITION TO ELOCTATE?

Every day, you're in charge of making choices that affect the way you live with Hemophilia A, including discussing with your healthcare provider which factor and treatment regimen may be right for you.

When considering any treatment plan, the first step is talking to your doctor. It's the best way to learn more about ELOCTATE and see if it's right for you.

Every question is an important one, especially when you want to learn more about a treatment. The Doctor Discussion Guide can help you know what questions to ask about ELOCTATE. There is also space to write down your own questions and take notes on information you want to remember accurately.

DOWNLOAD THE DOCTOR DISCUSSION GUIDE
“Michael and I did the research
together. He was included in the
entire decision-making process.”
— Charity, her son is on ELOCTATE.
Note: This is a personal account of a MyELOCTATE Peer™. Please talk to your healthcare provider about whether ELOCTATE may be right for you. Individual results may vary.

Indications and Important Safety Information

Indications

ELOCTATE [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. ELOCTATE is not indicated for the treatment of von Willebrand disease.

Important Safety Information

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called, "inhibitors," against ELOCTATE, which may stop ELOCTATE from working properly.

The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.

©2017 Bioverativ. All rights reserved.